Chongqing Zhifei Biological Products Co., Ltd.

Shenzhen Stock Exchange 300122.SZ

Chongqing Zhifei Biological Products Co., Ltd. Price to Book Ratio (P/B) on January 14, 2025: 1.84

Chongqing Zhifei Biological Products Co., Ltd. Price to Book Ratio (P/B) is 1.84 on January 14, 2025, a -50.46% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Chongqing Zhifei Biological Products Co., Ltd. 52-week high Price to Book Ratio (P/B) is 4.09 on March 04, 2024, which is 121.77% above the current Price to Book Ratio (P/B).
Chongqing Zhifei Biological Products Co., Ltd. 52-week low Price to Book Ratio (P/B) is 1.57 on September 13, 2024, which is -14.71% below the current Price to Book Ratio (P/B).
Chongqing Zhifei Biological Products Co., Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 2.53.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Shenzhen Stock Exchange: 300122.SZ

Chongqing Zhifei Biological Products Co., Ltd.

CEO	Mr. Rensheng Jiang
IPO Date	Sept. 28, 2010
Location	China
Headquarters	No. 7 Jinyuan Road
Employees	6,545
Sector	Health Care
Industries Biotechnology Pharmaceuticals Vaccines

Description

Chongqing Zhifei Biological Products Co., Ltd. engages in the research, development, manufacture, and marketing of vaccines and biological products in China. The company was founded in 2009 and is based in Chongqing, China.

Key trends

Past 5 years